ArticleFrontiers in cardiovascular medicine2026

Early use of levosimendan to improve survival and neurological outcomes after cardiac arrest with myocardial dysfunction: a protocol for a randomized controlled trial.

Zhen De et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.